The multinational company Bayer has confirmed a significant investment of $200 million for the construction of a new production plant in Costa Rica.
This strategic project will result in the creation of 300 new skilled jobs in the country, strengthening the advanced manufacturing sector.
Investment Details
The new production plant will be located in the Coyol Free Zone, in Alajuela.
The facilities will specialize in the manufacturing of high-tech medical devices, specifically long-acting reversible contraceptives. This operation is classified as high-value-added manufacturing, a key segment for the Costa Rican economy.
Impact on the National Economy
The impact of this investment extends beyond the 300 direct jobs that will be generated. The project is expected to produce positive secondary effects on the national economy:
- Productive Linkages: An increase in demand for services and materials from local suppliers is anticipated, stimulating auxiliary industries.
- Local Development: The operation will strengthen economic activity in the province of Alajuela and its surrounding communities.
- Country Positioning: This investment reinforces Costa Rica’s position as a global leader in the “Life Sciences” sector.
Bayer’s decision underscores the international confidence in the country’s human talent and investment climate, which can serve as a catalyst to attract future high-profile investments in this and other technological sectors.
